Self-Assembly Cascade Reaction Platform for CD44 Positive Lung Cancer Therapy.

Miao, Haitao; Zhu, Xiaoxiao; Yuan, Fei; Su, Qing; Li, Pei; Li, Wanyu; Zhao, Diandian; Chang, Jianhua

Miao, Haitao; Zhu, Xiaoxiao; Yuan, Fei; Su, Qing; Li, Pei; Li, Wanyu; Zhao, Diandian; Chang, Jianhua.

Afiliación

Miao H; Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, 200127, China.
Zhu X; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200000, China.
Yuan F; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200000, China.
Su Q; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200000, China.
Li P; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200000, China.
Li W; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200000, China.
Zhao D; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200000, China.
Chang J; Department of Medical Oncology, Shanghai Medical College, Fudan University, Shanghai, 200127, China.

J Biomed Nanotechnol ; 17(12): 2374-2381, 2021 Dec 01.

Article en En | MEDLINE | ID: mdl-34974860

Asunto(s)

Neoplasias Pulmonares; Nanopartículas; Humanos; Receptores de Hialuranos; Ácido Hialurónico; Peróxido de Hidrógeno; Neoplasias Pulmonares/tratamiento farmacológico; Polietileneimina

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biomed Nanotechnol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google